MedPath

Hepatocellular Carcinoma Surveillance in Patients with Chronic Hepatitis B Infection: A cohort Study

Phase 3
Active, not recruiting
Conditions
Hepatocellular carcinoma
Chronic Hepatitis B
Ultrasound
Surveillance
Hepatocelluar carcinoma
Registration Number
TCTR20160124001
Lead Sponsor
Chulabhorn Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
2200
Inclusion Criteria

1. HBsAg positive for more than 6 months

Exclusion Criteria

1. History of malignancy in the last 5 years except early stage skin cancer
2. Decompensated liver cirrhosis
3. Kanofsky performance status < 60
4. Creatinine clearance < 50 ml/min
5. Prior received antiviral treatment
6. HCV or HIV infection

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hepatocellular carcinoma incidence&#44; HCC respectability rate and tumor stage every 6 month Ultrasound
Secondary Outcome Measures
NameTimeMethod
Survival in HCC patients 5 year after diagnosed with HCC survival time
© Copyright 2025. All Rights Reserved by MedPath